This post may contain affiliate links. Read our disclosure policy.
Dimetapp hasn’t been taken off the market. It’s just that the FDA warned that inexact dosing could lead to an overdose in children; GSK has not reported any adverse effects so far.
The recalled lots of Robitussin and Dimetapp were distributed nationwide between Feb. 5 and June 3 and carry the GSK and Pfizer brand names on their labels.